'the why' | imugene, developing cancer immunotherapies asx: imu
Published 1 year ago • 2.9K plays • Length 4:51Download video MP4
Download video MP3
Similar videos
-
7:40
imugene limited (asx: imu) emergence 2024: presentation by leslie chong, managing director and ceo
-
4:49
imugene her-vaxx video asx: imu | an emerging leader in cancer immuno-oncology
-
53:26
developing cancer cures through the asx | going public w leslie chong & paul hopper
-
18:46
imugene (asx: imu) presentation | nwr virtual healthcare conference
-
6:16
imugene's new cancer therapy cd19 (oncarlytics) considered the 'holy grail'
-
26:23
imugene (asx:imu) presentation, nwr virtual healthcare conference
-
24:02
imugene forges development path of immunotherapies and cancer-killing virus
-
1:01
imugene (asx: imu) promo | behind the scenes with host laurence fishburne
-
5:04
imugene (asx:imu) | jmm & éthica capital innovation interview \ may 2024
-
9:16
imugene ceo leslie chong presents at wholesale investor's virtual showcase july 2020
-
18:08
asx/ausbiz biotech unlocked with imugene ceo leslie chong
-
0:43
how imugene (asx: imu) is changing the lives of cancer patients #shorts
-
5:15
imugene featured on behind the scenes with host laurence fishburne.
-
4:11
imugene limited (asx: imu) | snn network
-
26:56
investor presentation post asx news: imugene and eureka therapeutics oncarlytics collaboration
-
20:57
imugene (asx: imu) - discussing imu's 2022 biotech opportunity
-
15:06
imugene (asx:imu) | jmm & éthica capital innovation & investment insights | may 2024
-
4:12
imugene's ceo interviewed on ausbiz detailing a clinical trial deal with merck germany and pfizer.
-
3:15
imugene's her-vaxx immunotherapy treatment: explained